DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,799,701 | -11.1% | 47,960 | -13.3% | 8.16% | +1.2% |
| Q2 2023 | $13,277,778 | -7.9% | 55,324 | -3.3% | 8.06% | -12.4% |
| Q1 2023 | $14,409,103 | -3.0% | 57,222 | +2.2% | 9.20% | -10.8% |
| Q4 2022 | $14,856,299 | -7.8% | 55,973 | -10.3% | 10.31% | -0.7% |
| Q3 2022 | $16,121,000 | +1.8% | 62,416 | -0.1% | 10.38% | +4.4% |
| Q2 2022 | $15,843,000 | -14.3% | 62,491 | -0.8% | 9.95% | +4.8% |
| Q1 2022 | $18,484,000 | -12.8% | 63,015 | -2.2% | 9.49% | +1.7% |
| Q4 2021 | $21,204,000 | +9.2% | 64,448 | +1.1% | 9.33% | +4.2% |
| Q3 2021 | $19,416,000 | +13.7% | 63,776 | +0.3% | 8.96% | +10.9% |
| Q2 2021 | $17,071,000 | +20.1% | 63,611 | +0.7% | 8.08% | +8.8% |
| Q1 2021 | $14,216,000 | +3.4% | 63,160 | +2.0% | 7.43% | -2.8% |
| Q4 2020 | $13,752,000 | +5.2% | 61,905 | +2.0% | 7.64% | -12.1% |
| Q3 2020 | $13,072,000 | +23.6% | 60,706 | +1.5% | 8.69% | +10.5% |
| Q2 2020 | $10,574,000 | +32.6% | 59,798 | +3.8% | 7.87% | -2.5% |
| Q1 2020 | $7,976,000 | -5.7% | 57,623 | +4.6% | 8.07% | +27.8% |
| Q4 2019 | $8,455,000 | +6.4% | 55,085 | +0.1% | 6.31% | +3.5% |
| Q3 2019 | $7,950,000 | +3.8% | 55,041 | +2.7% | 6.10% | +2.0% |
| Q2 2019 | $7,656,000 | +11.6% | 53,572 | +3.1% | 5.98% | +3.7% |
| Q1 2019 | $6,861,000 | +24.1% | 51,974 | -3.1% | 5.77% | +4.5% |
| Q4 2018 | $5,530,000 | – | 53,629 | – | 5.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |